The FDA approved Seattle Genetics’ Adcetris (brentuximab vedotin)
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
On Oct. 12, 2010, HaloSource completed its IPO on the London Stock Exchange and raised $50 million in…
On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…
On Sept. 15, 2010, Pacific Northwest Diabetes Research Institute appointed Jack Faris, Ph.D., as Chief Executive Officer. Previously,…
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
On Jun. 30, 2010, SonoSite acquired VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9…
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
On Oct. 8, 2009, Omeros Corp. launched an initial public offering at $10.00 per share and raised $62.1…
In Sept. 2009, Seattle Cancer Care Alliance (SCCA) House opened. A state-of-the-art, 80-room, ‘green building,’ SCCA House offers…
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
On Nov. 21, 2008, the Washington State Academy of Sciences (WSAS) was launched. Authorized by the state legislature…
On Oct. 22, 2008, Merck announced it was closing its Rosetta Research Center and would layoff 300 employees…
On Aug. 20, 2008, Sonus Pharmaceuticals was acquired by OncoGenex Technologies in a reverse merger transaction worth $10.36…
On Jun. 18, 2008, Fred Hutch researchers described the first successful use of a human patient’s cloned infection-fighting…
Washington BioEvolution illustrates life science companies and non-profit research organization in the State of Washington by the year…
On Mar. 2, 2008, adult stem cells may provide an explanation for the cause of a Hutchinson-Gilford Progeris…
On Feb 25, 2008, the Pacific Northwest Research Institute changed its name to Pacific Northwest Diabetes Research Institute…
On Jan. 17, 2008, ZymoGenetics received U.S. Food and Drug Administration (FDA) authorization to manufacture the product Thrombin…
On Dec. 4, 2007, representatives of 111 countries and 29 international organizations met in New Delhi India for…
On Oct. 9, 2007, the Fred Hutchinson Business Alliance announced that the 2007 E. Donnall Thomas Medal of…
On Aug. 24, 2007, BioLife Solutions was incorporated in Seattle. BioLife Solutions (formerly Cryomedical Sciences) is a class-defining…
On Aug. 16. 2007, surgeons at the University of Washington (UW) Medical Center performed Seattle’s first adult heart-lung…
On Jul. 15, 2007, Dr. Jim Olson and colleagues from Fred Hutchinson Cancer Research Center and Seattle Children’s…
On Jan. 29, 2007, Eli Lilly announced it had completed its acqusition of ICOS Corp. for $2.3 billion…
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…